Potassium

A-GAME Beverages Inc. Signs Tim Hardaway Sr. and Paul Laroche as Brand Ambassadors

Retrieved on: 
Wednesday, November 8, 2023
Male, Gold, NFL, Sodium, Major League Baseball, La Roche, NBA, NBA scoring leaders, Family, National Basketball Association, 1991–92 Golden State Warriors season, World Series, Summer Olympic Games, Dallas Mavericks, Athlete, Major League Baseball All-Star Game, NASCAR, Golden, Indiana Pacers, Partnership, Denver Nuggets, All-NBA Team, Potassium, Drink, Sport

ORLANDO, Fla., Nov. 8, 2023 /PRNewswire/ -- A-GAME Beverages Inc., maker of A-GAME, the ultimate hydration beverage, is pleased to announce five-time NBA All-Star, Tim Hardaway Sr. and performance expert, Paul Laroche have joined A-GAME as brand ambassadors.

Key Points: 
  • ORLANDO, Fla., Nov. 8, 2023 /PRNewswire/ -- A-GAME Beverages Inc., maker of A-GAME, the ultimate hydration beverage, is pleased to announce five-time NBA All-Star, Tim Hardaway Sr. and performance expert, Paul Laroche have joined A-GAME as brand ambassadors.
  • As part of the partnership, Hardaway Sr. and Laroche will promote A-GAME leveraging their social following, community engagement, and involvement in the athletic community.
  • Tim Hardaway Sr. commented, "I am very happy and excited to be a part-of this unique hydration drink called A-GAME.
  • A-GAME, Hardaway Sr., and Laroche will come together to promote healthy lifestyles and active living to inspire others to be their best selves.

New Study Highlights Connection with Strawberries, Cognition and Mood in Middle-Aged, Overweight Adults

Retrieved on: 
Wednesday, November 8, 2023
Taste, Alzheimer's disease, Phytosterol, Ageing, DSM-IV codes, Public, Rush University, C, Psychiatry, University of Cincinnati Academic Health Center, Polyphenol, Dementia, Inflammation, Research, Prediabetes, California Strawberry Commission, Nursing, Risk, University, Anthocyanin, Woman, Randomized controlled trial, Grammatical mood, Potassium, Memory, Dietary supplement, Aroma compound, Nutrient

WATSONSVILLE, Calif., Nov. 8, 2023 /PRNewswire/ -- A new study published in Nutrients shows daily consumption of strawberries for 12 weeks reduced interference in memory and depressive symptoms among middle-aged, overweight adults with self-reported mild cognitive decline.

Key Points: 
  • One group received a strawberry powder prepared from whole fruit that had been desiccated, freeze-dried and milled.
  • Daily servings of strawberry and control powder were sealed in packets for the convenience of the participants and to control daily dosage.
  • Participants were also asked to discontinue consumption of all berry fruits, juices and extracts for the duration of the study.
  • And, long-term observational studies, including the Health Professionals Study and the Nurses' Health Study, found that strawberry consumers had lower rates of cognitive decline," explains Christian.

A-GAME Beverages Inc. Signs Tim Hardaway Sr. and Paul Laroche as Brand Ambassadors

Retrieved on: 
Thursday, November 9, 2023
Male, Gold, NFL, Sodium, Major League Baseball, La Roche, NBA, NBA scoring leaders, Family, National Basketball Association, 1991–92 Golden State Warriors season, World Series, Summer Olympic Games, Dallas Mavericks, Athlete, Major League Baseball All-Star Game, NASCAR, Golden, Indiana Pacers, Partnership, Denver Nuggets, All-NBA Team, Potassium, Drink, Sport

ORLANDO, Fla., Nov. 8, 2023 /PRNewswire/ -- A-GAME Beverages Inc., maker of A-GAME, the ultimate hydration beverage, is pleased to announce five-time NBA All-Star, Tim Hardaway Sr. and performance expert, Paul Laroche have joined A-GAME as brand ambassadors.

Key Points: 
  • ORLANDO, Fla., Nov. 8, 2023 /PRNewswire/ -- A-GAME Beverages Inc., maker of A-GAME, the ultimate hydration beverage, is pleased to announce five-time NBA All-Star, Tim Hardaway Sr. and performance expert, Paul Laroche have joined A-GAME as brand ambassadors.
  • As part of the partnership, Hardaway Sr. and Laroche will promote A-GAME leveraging their social following, community engagement, and involvement in the athletic community.
  • Tim Hardaway Sr. commented, "I am very happy and excited to be a part-of this unique hydration drink called A-GAME.
  • A-GAME, Hardaway Sr., and Laroche will come together to promote healthy lifestyles and active living to inspire others to be their best selves.

Cerevance Announces Presentation at the SFN Neuroscience 2023 Annual Meeting

Retrieved on: 
Tuesday, November 7, 2023
Potassium, Gene expression, Therapy, Pathology, KCNJ10, CNS, Society, Disease, Date, Cerev Del, Annual general meeting, Astrocyte, Central nervous system, Vaccine, Neuroscience

BOSTON, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Cerevance, a company focused on developing novel precision therapeutics for central nervous system (CNS) diseases, today announced plans to present a poster presentation at the Neuroscience 2023 Annual Meeting presented by the Society for Neuroscience, taking place in Washington, D.C., November 11 – 15th, 2023.

Key Points: 
  • BOSTON, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Cerevance, a company focused on developing novel precision therapeutics for central nervous system (CNS) diseases, today announced plans to present a poster presentation at the Neuroscience 2023 Annual Meeting presented by the Society for Neuroscience, taking place in Washington, D.C., November 11 – 15th, 2023.
  • Overview: Gene expression relevant to human disease pathology can be observed using Cerevance’s proprietary NETSseq platform.
  • Data from this approach demonstrated that KCNJ10 is expressed in astrocytes from post-mortem brain tissue of Alzheimer’s and Parkinson’s disease donors and is increased in disease.
  • Session and Date and Time: Potassium Channels; November 15th, 8am – 12pm ET

Menarini Group and SciClone Pharmaceuticals Announce Exclusive Sub-Licensing Collaboration to Develop and Commercialize ORSERDU® (Elacestrant) in China to Address Advanced or Metastatic Breast Cancer

Retrieved on: 
Tuesday, November 7, 2023
Biotechnology, Health, Pharmaceutical, Clinical Trials, Oncology, Neoplasm, Abdominal pain, Constipation, SOC, Headache, Food, Progression-free survival, European Commission, Vomiting, Diarrhea, Prevalence, PFS, Safety, DSM-IV codes, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, HIV disease progression rates, Holding, Nausea, Multimedia, Civil service commission, ESR1, Risk, Triglyceride, MBC, ER, Breast cancer, Anemia, Woman, Indigestion, Cancer, Therapy, Arthralgia, Patient, Creatinine, Potassium, Death, Back pain, Cholesterol, Fatigue, Pharmaceutical industry

Stemline Therapeutics, a wholly-owned subsidiary of the Menarini Group, focused on bringing transformational oncology treatments to cancer patients, commercializes ORSERDU in the U.S. and E.U.

Key Points: 
  • Stemline Therapeutics, a wholly-owned subsidiary of the Menarini Group, focused on bringing transformational oncology treatments to cancer patients, commercializes ORSERDU in the U.S. and E.U.
  • Under the Sub-Licensing agreement, SciClone will pursue the development and registration of ORSERDU in China and commercialize ORSERDU upon its regulatory approval in China.
  • “Patients living with metastatic breast cancer need effective and tolerable options,” said Elcin Barker Ergun, CEO of the Menarini Group.
  • The primary endpoints of the study were PFS in the overall patient population and in patients with ESR1 mutations.

Menarini Group and SciClone Pharmaceuticals Announce Exclusive Sub-Licensing Collaboration to Develop and Commercialize ORSERDU® (Elacestrant) in China to Address Advanced or Metastatic Breast Cancer

Retrieved on: 
Tuesday, November 7, 2023
Neoplasm, Patient, Abdominal pain, Constipation, SOC, Headache, Food, Progression-free survival, Fatigue, European Commission, Vomiting, Diarrhea, PFS, Safety, DSM-IV codes, HIV disease progression rates, Holding, Nausea, Republic, Civil service commission, ESR1, Risk, Triglyceride, MBC, ER, Breast cancer, Anemia, Woman, Oncology, Indigestion, Cancer, Therapy, Arthralgia, Creatinine, Potassium, Death, Back pain, Cholesterol, Mutation, Menarini, Medical imaging, Pharmaceutical industry

Stemline Therapeutics, a wholly-owned subsidiary of the Menarini Group, focused on bringing transformational oncology treatments to cancer patients, commercializes ORSERDU in the U.S. and E.U.

Key Points: 
  • Stemline Therapeutics, a wholly-owned subsidiary of the Menarini Group, focused on bringing transformational oncology treatments to cancer patients, commercializes ORSERDU in the U.S. and E.U.
  • Under the Sub-Licensing agreement, SciClone will pursue the development and registration of ORSERDU in China and commercialise ORSERDU upon its regulatory approval in China.
  • "Patients living with metastatic breast cancer need effective and tolerable options," said Elcin Barker Ergun, CEO of the Menarini Group.
  • "We are proud to partner with SciClone in an effort to register a new breast cancer treatment for patients in China that can offer efficacy in a once-daily pill."

Menarini Group and SciClone Pharmaceuticals Announce Exclusive Sub-Licensing Collaboration to Develop and Commercialize ORSERDU® (Elacestrant) in China to Address Advanced or Metastatic Breast Cancer

Retrieved on: 
Tuesday, November 7, 2023
Neoplasm, Patient, Abdominal pain, Constipation, SOC, Headache, Food, Progression-free survival, Fatigue, European Commission, Vomiting, Diarrhea, PFS, Safety, DSM-IV codes, HIV disease progression rates, Holding, Nausea, Republic, Civil service commission, ESR1, Risk, Triglyceride, MBC, ER, Breast cancer, Anemia, Woman, Oncology, Indigestion, Cancer, Therapy, Arthralgia, Creatinine, Potassium, Death, Back pain, Cholesterol, Mutation, Menarini, Medical imaging, Pharmaceutical industry

Stemline Therapeutics, a wholly-owned subsidiary of the Menarini Group, focused on bringing transformational oncology treatments to cancer patients, commercializes ORSERDU in the U.S. and E.U.

Key Points: 
  • Stemline Therapeutics, a wholly-owned subsidiary of the Menarini Group, focused on bringing transformational oncology treatments to cancer patients, commercializes ORSERDU in the U.S. and E.U.
  • Under the Sub-Licensing agreement, SciClone will pursue the development and registration of ORSERDU in China and commercialise ORSERDU upon its regulatory approval in China.
  • "Patients living with metastatic breast cancer need effective and tolerable options," said Elcin Barker Ergun, CEO of the Menarini Group.
  • "We are proud to partner with SciClone in an effort to register a new breast cancer treatment for patients in China that can offer efficacy in a once-daily pill."

Natalie's Orchid Island Juice Company Expands Holistic Juice Portfolio with Two New Tomato and Super Mushroom Blends

Retrieved on: 
Monday, October 30, 2023
Taste, Pineapple, QFC, Lycopene, Juice, Fry, Smith, King Soopers, Holism, Light, Kroger, Lingzhi (mushroom), Risk, Antioxidant, Black pepper, Mane, Cancer, Potassium, Natalie, Wine, Food preservation, Ralphs

FORT PIERCE, Fla., Oct. 30, 2023 /PRNewswire/ -- Natalie's Orchid Island Juice Company, the world-class juice brand known for crafting clean-label, mindfully sourced artisanal blends, today announced the introduction of two tomato-centric blends: Red Tomato Reishi and Green Tomato Lion's Mane. The expansion of Natalie's Holistic Juice Portfolio is a natural evolution for the brand that has been handcrafting unrivaled juices for more than 30 years. Both blends are available to order on the Natalie's Juice website and at Kroger, King Soopers, Fry's, Ralphs, Smith's, Fred Meyer and QFC nationwide beginning today.

Key Points: 
  • The expansion of Natalie's Holistic Juice Portfolio is a natural evolution for the brand that has been handcrafting unrivaled juices for more than 30 years.
  • Both blends are available to order on the Natalie's Juice website and at Kroger, King Soopers, Fry's, Ralphs, Smith's, Fred Meyer and QFC nationwide beginning today.
  • "Today's consumers are searching for products that offer a holistic approach to their overall well-being," says Marygrace Sexton, Founder and CEO of Natalie's Orchid Island Juice Company.
  • To purchase Natalie's new tomato blends, learn more about the brand's award-winning collection of juices or locate your nearest retailer, please visit www.oijc.com

Pumpkin waste: three ways to stop your leftover lantern becoming a Halloween horror story

Retrieved on: 
Thursday, October 26, 2023
Social media, Water, Food, Cooking, Bread, Family, Farm, Copper, Coffee, Carbon, Research, Creativity, Friends, Methane, Environment, Edible, Internet, Plant, Animal, Drink, Snack, Greenhouse, Potassium, Climate change, Iron, Vegetable, Cosmetics

When a pumpkin is wasted, the water, energy and labour used to grow and distribute it is also wasted.

Key Points: 
  • When a pumpkin is wasted, the water, energy and labour used to grow and distribute it is also wasted.
  • Then when a pumpkin decomposes in a landfill it emits methane, which is a more potent greenhouse gas than carbon dioxide.
  • So I know that people can eliminate these negative impacts of pumpkin waste by simply using leftover pumpkins.
  • However, it is crucial to remember that leftover pumpkin should be stored in the fridge and will last for a few days.

Standard Lithium Delivers Highest-Ever North American Lithium Brine Grade 806 mg/L; East Texas Asset Includes Significant Potash and Bromine Concentrations

Retrieved on: 
Wednesday, October 25, 2023
Lithium, Dorado, FRA, NYSE, Economics, Potassium chloride, News, Smackover Formation, Arkansas Project, SLI, Bromine, Mineral, Potassium

As part of its extensive work in East Texas, the Company has drilled and sampled a new highest confirmed lithium grade brine, measuring 806 mg/L.

Key Points: 
  • As part of its extensive work in East Texas, the Company has drilled and sampled a new highest confirmed lithium grade brine, measuring 806 mg/L.
  • In addition, comprehensive brine analyses from all three of the Company’s new wells in East Texas show highly elevated concentrations of potash (KCl) and bromine, signifying a large potential for these commodities.
  • Dr. Andy Robinson, President and COO of Standard Lithium commented, “This most recent brine sample from our newest well in East Texas confirms the exceptional quality of the lithium brine assets we’re acquiring in East Texas.
  • With a new confirmed lithium analysis of 806 mg/L and an average grade of 644 mg/L in our drilled area, we believe that we have identified a globally significant lithium brine asset.